First results with ICS 205-930 (5-HT3 receptor antagonist) in prevention of chemotherapy-induced emesis.

Suppr

超能文献

作者信息

Leibundgut U, Lancranjan I

出版信息

Lancet. 1987 May 23;1(8543):1198. doi: 10.1016/s0140-6736(87)92159-3.

DOI:10.1016/s0140-6736(87)92159-3

PMID:2883502

Abstract

摘要

相似文献

First results with ICS 205-930 (5-HT3 receptor antagonist) in prevention of chemotherapy-induced emesis.

Lancet. 1987 May 23;1(8543):1198. doi: 10.1016/s0140-6736(87)92159-3.

Prevention of emesis by tropisetron in children receiving combined chemotherapy with cisplatin.

Pediatr Hematol Oncol. 1995 Sep-Oct;12(5):479-83. doi: 10.3109/08880019509009478.

Prevention of emesis by ICS 205-930 in children receiving cytotoxic chemotherapy.ICS 205-930对接受细胞毒性化疗的儿童呕吐的预防作用。

Eur J Cancer. 1993;29A(6):854-6. doi: 10.1016/s0959-8049(05)80423-x.

Tropisetron (ICS 205-930) in pediatric oncology: first results in patients refractory to antiemetic metoclopramide-based treatments.托烷司琼（ICS 205-930）在儿童肿瘤学中的应用：基于甲氧氯普胺的止吐治疗无效患者的初步结果

Am J Pediatr Hematol Oncol. 1994 Aug;16(3):242-5.

Comparison of oral 5-HT3-receptor antagonists and low-dose oral metoclopramide plus i.m. dexamethasone for the prevention of delayed emesis in head and neck cancer patients receiving high-dose cisplatin.口服5-羟色胺3受体拮抗剂与小剂量口服胃复安加肌肉注射地塞米松预防接受大剂量顺铂治疗的头颈癌患者迟发性呕吐的比较。

Oncol Rep. 1998 Jan-Feb;5(1):273-80. doi: 10.3892/or.5.1.273.

A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.一份关于在严重呕吐情况下，将5-羟色胺3受体拮抗剂托烷司琼（呕必停）与地塞米松和胃复安的标准止吐方案用于顺铂治疗患者的比较报告。

Semin Oncol. 1994 Oct;21(5 Suppl 9):3-6.

A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis.一项评估托烷司琼联合地塞米松预防铂类药物所致迟发性恶心和呕吐的疗效及耐受性的研究。

Cancer. 1998 Sep 1;83(5):1022-32.

Tropisetron: an update of its use in the prevention of chemotherapy-induced nausea and vomiting.托烷司琼：其在预防化疗引起的恶心和呕吐方面应用的最新进展

Drugs. 2000 Jun;59(6):1297-315. doi: 10.2165/00003495-200059060-00008.

[Tropisetron hydrochloride in preventing and treating chemotherapy-induced nausea and vomiting: a phase II, randomized, multicenter, double-blinded, comparative clinical trial].

Ai Zheng. 2007 Aug;26(8):870-3.

[Effects of oral 5-HT3 antagonists on chemotherapy-induced emesis in patients with gynecologic cancers].[口服5-羟色胺3拮抗剂对妇科癌症患者化疗引起呕吐的影响]

Gan To Kagaku Ryoho. 2000 Apr;27(4):593-8.

引用本文的文献

Prevention of Chemotherapy-Induced Nausea and Vomiting in the Older Patient: Optimizing Outcomes.老年患者化疗所致恶心和呕吐的预防：优化结局。

Drugs Aging. 2022 Jan;39(1):1-21. doi: 10.1007/s40266-021-00909-8. Epub 2021 Dec 9.

Anticholinergic, antihistaminic, and antiserotonergic activity of n-hexane extract of seeds on isolated tissue preparations: An study.种子正己烷提取物对离体组织制剂的抗胆碱能、抗组胺能和抗血清素能活性：一项研究。

Indian J Pharmacol. 2017 Jan-Feb;49(1):42-48. doi: 10.4103/0253-7613.201025.

Pharmacological Agents Affecting Emesis : A Review (Part II).影响呕吐的药物制剂：综述（第二部分）

Drugs. 1992 Apr;43(4):443-463. doi: 10.2165/00003495-199243040-00003.

Anticipatory nausea in animal models: a review of potential novel therapeutic treatments.动物模型中的预期性恶心：潜在新型治疗方法综述

Exp Brain Res. 2014 Aug;232(8):2511-34. doi: 10.1007/s00221-014-3942-9. Epub 2014 May 4.

[Management of chemotherapy-induced emesis: what is the standard after 20 years of clinical research].[化疗引起的呕吐的管理：经过20年临床研究后何为标准]

Med Klin (Munich). 1998 Jan;93 Suppl 1:3-17. doi: 10.1007/BF03041988.

The effects of gamma-radiation on intestinal motor activity and faecal pellet expulsion in the guinea pig.

Dig Dis Sci. 1996 Dec;41(12):2307-16. doi: 10.1007/BF02100119.

An open, randomized study to compare the efficacy and tolerability of tropisetron with that of a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis.

Cancer Chemother Pharmacol. 1994;33(4):298-302. doi: 10.1007/BF00685903.

The anti-emetic efficacy and tolerability of tropisetron in patients conditioned with high-dose chemotherapy (with and without total body irradiation) prior to bone marrow transplantation.托烷司琼在骨髓移植前接受大剂量化疗（有或无全身照射）预处理的患者中的止吐疗效及耐受性。

Support Care Cancer. 1994 Jul;2(4):245-8. doi: 10.1007/BF00365730.

Tropisetron. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential as an antiemetic.

Drugs. 1993 Nov;46(5):925-43. doi: 10.2165/00003495-199346050-00009.

Effect of ICS 205-930 (a specific 5-HT3 receptor antagonist) on gastric emptying of a solid meal in normal subjects.ICS 205-930（一种特异性5-羟色胺3受体拮抗剂）对正常受试者固体餐胃排空的影响。

Gut. 1988 Sep;29(9):1249-52. doi: 10.1136/gut.29.9.1249.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验